Related Experiment Video

Updated: Jul 20, 2026

High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
11:50

High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart

Published on: July 9, 2010

24.4K

Uraemic Cardiomyopathy: A Review of Current Literature

Kartheek Garikapati1, Daniel Goh1,2, Shaun Khanna1,2

  • 1Department of Internal Medicine, Toowoomba Hospital, Toowoomba, QLD, Australia.

Clinical Medicine Insights. Cardiology
|March 12, 2021
PubMed

Insights

Uraemic Cardiomyopathy (UC) significantly impacts End-Stage Renal Disease (ESRD) patients, increasing risks of arrhythmias and sudden cardiac death. Early diagnosis via imaging and targeted therapies are crucial, though further research is needed.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Uraemic Cardiomyopathy (UC) is a complex condition in End-Stage Renal Disease (ESRD) patients.
  • It significantly contributes to cardiovascular morbidity and mortality, including arrhythmias, cardiac failure, and sudden cardiac death (SCD).
  • Pathophysiology involves hemodynamic overload, uremic toxins, and the Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) pathway.

Purpose of the Study:

  • To summarize the current understanding of Uraemic Cardiomyopathy (UC) in ESRD patients.
  • To highlight the role of diagnostic imaging in UC.
  • To discuss current and potential therapeutic strategies for UC.

Main Methods:

  • Review of existing literature on Uraemic Cardiomyopathy (UC).
  • Emphasis on multi-modality imaging techniques such as transthoracic echocardiography and cardiac magnetic resonance imaging.
  • Discussion of pharmacotherapy, dialysis, and renal transplantation as treatment options.

Main Results:

  • UC is characterized by left ventricular hypertrophy and myocardial fibrosis.
  • Multi-modality imaging is instrumental in diagnosing UC hallmarks.
  • Current therapies include beta-blockers, aldosterone-antagonists, hemodialysis, and renal transplantation.

Conclusions:

  • Effective therapeutic interventions for UC remain limited.
  • Ongoing cellular-level research is vital for developing novel therapies.
  • Integrated diagnostic and therapeutic approaches are essential for managing UC in ESRD patients.

Keywords:
FGF 23Uraemic cardiomyopathychronic kidney disease-bone mineral diseaseend-stage renal diseaseklotholeft ventricular hypertrophy

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.3K
Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.9K

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...